CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SMiPAX4 project investigates how small molecules reduce immune responses by targeting the CXCR4 receptor. It employs various biochemical techniques to explore signaling pathways and protein interactions, aiming to advance understanding in immunology and pharmacology with potential applications in treating autoimmun…
The following project, SMiPAX4, conducted in the academic group of Jean-Philippe Herbeuval (Univeristy of Paris, France), is at the cross section of immunology and pharmacology.
Moreover, due to its direct application potential and the subsequent industrial placement to deepen the acquired knowledge at Sanofi it is also cross sectional between academia and industry.
The main objective of the project is to understand the mode of action of small molecules, functionally causing a reduction of immun…
UNIVERSITE PARIS CITE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, GENTILLY
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
